Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/10232294
Conclusion of this study
Omega3 fatty acids were well tolerated and improved the short-term course of illness in this preliminary study of patients with bipolar disorder.
Supplements analyzed in this study
|
Health conditions analyzed in this study
|
||
|
Functions related to this study
|
||
|
Body systems related to this study
Nervous System |